Progyny director Kevin Gordon sells $321,358 in company stock

Progyny director Kevin Gordon sold 11,500 shares of the company's stock on September 10, 2026, for a total of $321,358, according to Investing.com. This sale occurred after the stock had surged 59% over the previous six months, though it remains undervalued according to InvestingPro's analysis, which suggests a price target of $33.00 per share with a Market Outperform rating.

Despite the insider sale, Progyny reported strong second-quarter results for 2026, exceeding analyst expectations with adjusted earnings of $0.55 per share and revenue of $350.51 million. The company also announced a partnership with CalPERS and is expanding its addressable market through a new pooled risk, fixed premium offering.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.